1-10 of 10
anthracycline antibiotics
Close
Sort by
Journal Articles

Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.

Journal: Blood Advances
Blood Adv (2021) 5 (12): 2576.
https://doi.org/10.1182/bloodadvances.2021005072
Published: 2021
Journal Articles

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Clinical Trials & Observations
Alden A. Moccia, Kimberly Schaff, Ciara Freeman, Paul J. Hoskins, Richard J. Klasa, Kerry J. Savage, Tamara N. Shenkier, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1483–1489.
https://doi.org/10.1182/bloodadvances.2020002982
Published: 2021
Includes: Supplemental data
Journal Articles

Primary human herpesvirus 8–negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis

Daisuke Kaji, Yasunori Ota, Yasuharu Sato, Koji Nagafuji, Yasunori Ueda, Masataka Okamoto, Yasushi Terasaki, Naoko Tsuyama, Kosei Matsue, Tomohiro Kinoshita, Go Yamamoto, Shuichi Taniguchi, Shigeru Chiba, Koichi Ohshima, Koji Izutsu
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4442–4450.
https://doi.org/10.1182/bloodadvances.2020002293
Published: 2020
Includes: Supplemental data
Journal Articles

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Clinical Trials & Observations
Shu-Nan Qi, Yong Yang, Yu-Qin Song, Ying Wang, Xia He, Chen Hu, Li-Ling Zhang, Gang Wu, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Fu-Quan Zhang, Xue-Ying Qiao, Hua Wang, Gao-Feng Li, Hui-Qiang Huang, Yu-Jing Zhang, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Li-Ming Xu, Zhi-Yong Yuan, Hang Su, Jun Zhu, Ye-Xiong Li
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3141–3153.
https://doi.org/10.1182/bloodadvances.2020001852
Published: 2020
Includes: Supplemental data
Journal Articles

Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States

Amer M. Zeidan, Nikolai A. Podoltsev, Xiaoyi Wang, Chi Zhang, Jan Philipp Bewersdorf, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma, Rong Wang
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1615–1623.
https://doi.org/10.1182/bloodadvances.2020001728
Published: 2020
Journal Articles

Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper

Clinical Trials & Observations
Nina Rosa Neuendorff, Kah Poh Loh, Alice S. Mims, Konstantinos Christofyllakis, Wee-Kheng Soo, Bediha Bölükbasi, Carlos Oñoro-Algar, William G. Hundley, Heidi D. Klepin
Journal: Blood Advances
Blood Adv (2020) 4 (4): 762–775.
https://doi.org/10.1182/bloodadvances.2019000955
Published: 2020
Journal Articles

Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)

Clinical Trials & Observations
Jun Yin, Betsy LaPlant, Geoffrey L. Uy, Guido Marcucci, William Blum, Richard A. Larson, Richard M. Stone, Sumithra J. Mandrekar
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1714–1721.
https://doi.org/10.1182/bloodadvances.2018026112
Published: 2019
Includes: Supplemental data
Journal Articles

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia

Clinical Trials & Observations
Brian Ball, Rami S. Komrokji, Lionel Adès, Mikkael A. Sekeres, Amy E. DeZern, Lisa Pleyer, Norbert Vey, Antonio Almeida, Ulrich Germing, Thomas Cluzeau, Uwe Platzbecker, Steven D. Gore, Pierre Fenaux, Thomas Prebet
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2063–2071.
https://doi.org/10.1182/bloodadvances.2018015529
Published: 2018
Includes: Supplemental data
Journal Articles

Prediction of cardiovascular disease among hematopoietic cell transplantation survivors

Clinical Trials & Observations
Saro H. Armenian, Dongyun Yang, Jennifer Berano Teh, Liezl C. Atencio, Alicia Gonzales, F. Lennie Wong, Wendy M. Leisenring, Stephen J. Forman, Ryotaro Nakamura, Eric J. Chow
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1756–1764.
https://doi.org/10.1182/bloodadvances.2018019117
Published: 2018
Includes: Supplemental data
Journal Articles

Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia

Clinical Trials & Observations
Antonio R. Lucena-Araujo, Diego A. Pereira-Martins, Luisa C. Koury, Pedro L. Franca-Neto, Juan L. Coelho-Silva, Virginia M. de Deus Wagatsuma, Raul A. M. Melo, Rosane Bittencourt, Katia Pagnano, Ricardo Pasquini, Carlos S. Chiattone, Evandro M. Fagundes, Maria de Lourdes Chauffaille, Stanley L. Schrier, Martin S. Tallman, Raul C. Ribeiro, David Grimwade, Arnold Ganser, Bob Löwenberg, Francesco Lo-Coco, Miguel A. Sanz, Nancy Berliner, Eduardo M. Rego
Journal: Blood Advances
Blood Adv (2017) 1 (21): 1807–1814.
https://doi.org/10.1182/bloodadvances.2017005926
Published: 2017
Includes: Supplemental data